PVLA Competitors & Alternatives
Compare Palvella Therapeutics, Inc with similar stocks in the same industry
Biotechnology
PVLA
Main Stock$139.04
Tradestie Score
51
Market Cap
$699.30M
Analyst Upside
+65.1%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IRON
Disc Medicine, Inc. Common Stock
|
$77.00
|
$2.33B | - | 60 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$30.02
|
$2.33B | - | 50 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.00
|
$2.23B | - | 54 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$22.57
|
$2.22B | - | 59 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$55.89
|
$2.21B | - | 59 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$23.02
|
$2.18B | - | 55 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.17
|
$2.08B | - | 49 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$14.86
|
$2.02B | 44.5 | 49 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$10.68
|
$2.01B | - | 50 | Compare |
More PVLA Analysis
Data updated: Aug 02, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry